Pharmaceuticals, Biotechnology and Life Sciences
NEW YORK–(BUSINESS WIRE)–#SICT2019—EpiVax Oncology, Inc., a precision cancer immunotherapy company, today announced that three abstracts highlighting its Ancer™ platform have…
– Revance’s long-acting neuromodulator DAXI will be featured in three abstracts and three oral presentations at the American Society for…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cedilla Therapeutics, a preclinical biotech company harnessing protein stability to create the next generation of targeted cancer therapies,…
White House Announcement made on October 22, 2019 GAINESVILLE, Fla.–(BUSINESS WIRE)–Cyclo Therapeutics, Inc. (OTCQB: CTDH), a clinical-stage biotechnology company that…
CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX #AMD—Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies…
— Once-Daily, Orally Administered CCR4 Antagonist Blocks Recruitment of Th2 Inflammatory Immune Cells — — Potential to Treat Allergic Inflammatory…
DUBLIN–(BUSINESS WIRE)–The “Global Schizophrenia Drugs (Orals & Injectables) Market: Insights, Trends and Forecast (2019-2023)” report has been added to ResearchAndMarkets.com’s…
Intend to identify EMM compositions that promote skeletal muscle growth and function across multiple disease contexts CAMBRIDGE, Mass.–(BUSINESS WIRE)–Axcella Health…
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF) today announced it will host a Key Opinion Leader (KOL) meeting on new, unique…
Pivotal trial to evaluate the safety and efficacy of novel, investigational cell therapy intended to durably free living donor kidney…